Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOTHER: Montelukast vs placebo in erosive/inflammatory hand osteoarthritis
2025-521802-17-00Phase 3Authorised
- Sponsor
- Farmalíder
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial in hand osteoarthritis comparing Montelukast arm with Placebo arm (2 arms). Planned start Oct 2025; status: authorised.
02
Drugs
montelukast
03
Conditions
hand osteoarthritis
Beyond the preview
Go deeper on 2025-521802-17-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-521802-17-00.